Alerts will be sent to your verified email
Verify Email
SOTAC
|
Sotac Pharmaceutical
|
Krebs Biochem.&Inds
|
Parnax Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-4.85 % | 56.46 % | 6.88 % |
|
5yr Avg Net Profit Margin
|
1.45 % | -60.0 % | 2.37 % |
|
Price to Book
|
0.0 | 0.0 | 1.77 |
|
P/E
|
18.94 | 0.0 | 13.64 |
|
5yr Avg Cash Conversion Cycle
|
3.3 Days | -861.42 Days | 42.8 Days |
|
5yr Average Interest Coverage Ratio
|
3.3 | -5.02 | 2.32 |
|
5yr Avg ROCE
|
19.17 % | -22.06 % | 15.17 % |
|
5yr Avg Operating Profit Margin
|
7.12 % | -38.55 % | 11.62 % |
|
5 yr average Debt to Equity
|
2.81 | -2.12 | 1.28 |
|
5yr CAGR Net Profit
|
116.49 % | -7.31 % | n/a |
|
5yr Average Return on Assets
|
1.93 % | -17.59 % | 2.67 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.85 % | 72.74 % | 72.3 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 9.41 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 4.72 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sotac Pharmaceutical
|
Krebs Biochem.&Inds
|
Parnax Lab
|
|---|